Rt-pa--Recombinant Human Tissue Type Plasminogen Activator Injection 20Mg

Rt-pa--Recombinant Human Tissue Type Plasminogen Activator Injection 20Mg

49000 INR

Product Details:

X

Rt-pa--Recombinant Human Tissue Type Plasminogen Activator Injection 20Mg Price And Quantity

  • 100000 Piece
  • 49000 INR

Rt-pa--Recombinant Human Tissue Type Plasminogen Activator Injection 20Mg Trade Information

  • Cash Advance (CA) Cash in Advance (CID)
  • 100000 Piece Per Week
  • 1 Week
  • Australia Africa Middle East South America Western Europe Asia Central America Eastern Europe North America

Product Description

Actilyse 20mg infusionicon

Uses of actilyse infusion:-actilyse 20mg infusion is used in the treatment of heart attack and stroke.

Side effects of actilyse infusion:- nausea, vomiting, decreased blood pressure, injection site bleeding.

How to use actilyse infusion:- your doctor or nurse will give you this medicine. Kindly do not self-administer.

How actilyse infusion works:-Actilyse 20mg infusion works by dissolving the harmful blood clots in the blood vessels. This allows reperfusion of affected tissue, preventing tissue death and improving outcomes.

In depth information on actilyse infusion:-

Warnings Special precautions for ACTILYSE 20MG INFUSION

Alcohol:- Interaction with alcohol is unknown. Please consult your doctor.

Pregnancy:-WEIGH RISKS VS BENEFITS Actilyse 20mg infusion may be unsafe to use during pregnancy.

Lactation:-SAFE Actilyse 20mg infusion is probably safe to use during breastfeeding. Please consult your doctor.

Driving:-There is no data available. Please consult doctor before consuming the drug.

Kidney:-There is no interaction between renal impairment and consumi

Liver:-There is no data available. Please consult doctor before consuming the drug.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Pharmaceutical Drugs' category



"Accepting orders in bulk order quantity".
trade india member
DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.